NWBO 8-K: Material Loan Agreement Filed

Northwest Biotherapeutics, Inc. (NWBO) filed an 8-K on October 27, 2025, announcing the entry into a material loan agreement pursuant to Item 1.01 and 2.03.

• Financing Secured: $5,505,000 Commercial Loan from Streeterville Capital, LLC.
• Key Cost Factors: The loan includes an 8% annual interest rate and a significant 10% Original Issue Discount (OID).
• Maturity & Repayment:
  • Maturity is 22 months.
  • Repayments are deferred for the first 8 months.
  • Amortization begins June 26, 2026, over 14 eq